# Intra-ovarian Injection of MSC-EVs in Idiopathic Premature Ovarian Failure

> **NCT06202547** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Royan Institute** · enrollment: 10 (estimated)

## Conditions studied

- Premature Ovarian Failure

## Interventions

- **BIOLOGICAL:** Intra-ovarian injection of bone marrow mesenchymal stromal cells-derived extracellular vesicles

## Key facts

- **NCT ID:** NCT06202547
- **Lead sponsor:** Royan Institute
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-02-20
- **Primary completion:** 2024-09-20
- **Final completion:** 2025-02-18
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2024-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06202547

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06202547, "Intra-ovarian Injection of MSC-EVs in Idiopathic Premature Ovarian Failure". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06202547. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*